Remimazolam Market Competitive Landscape

toegevoegd een audio Health

2026-06-17 10:55:43 -

The Remimazolam Market features a competitive landscape defined by strategic consolidation and innovation. Daiichi Sankyo strengthened its position through the USD 520 million acquisition of PAION AG's global remimazolam assets, securing worldwide development and commercialization rights. Hikma Pharmaceuticals partnered with Fresenius Kabi to co-develop remimazolam for Middle East and African...

0 Reacties 0 aandelen 79 Views 0 voorbeeld